At close: December 16 at 4:00:02 PM EST
After hours: December 16 at 6:49:05 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-526,592.00
-331,725.00
-297,689.00
-145,840.00
-75,957.00
Investing Cash Flow
-161,212.00
129,830.00
-304,790.00
944.00
-2,697.00
Financing Cash Flow
650,156.00
211,908.00
767,597.00
138,447.00
152,242.00
End Cash Position
88,342.00
252,120.00
242,604.00
77,057.00
83,506.00
Income Tax Paid Supplemental Data
--
--
38,165.00
16,594.00
2,758.00
Interest Paid Supplemental Data
--
--
--
107.00
--
Capital Expenditure
-4,470.00
-3,048.00
-41,074.00
-938.00
-2,697.00
Issuance of Capital Stock
638,106.00
243,225.00
283,804.00
--
--
Free Cash Flow
-531,062.00
-334,773.00
-338,763.00
-146,778.00
-78,654.00
12/31/2020 - 9/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRRK Scholar Rock Holding Corporation
42.87
+2.12%
RNA Avidity Biosciences, Inc.
33.39
+2.77%
CRNX Crinetics Pharmaceuticals, Inc.
54.63
+1.81%
ACLX Arcellx, Inc.
83.42
-0.45%
CYTK Cytokinetics, Incorporated
49.02
+0.76%
EWTX Edgewise Therapeutics, Inc.
32.69
+18.36%
AXSM Axsome Therapeutics, Inc.
89.68
-0.47%
ARVN Arvinas, Inc.
18.99
-2.62%
JANX Janux Therapeutics, Inc.
61.56
+0.74%
APGE Apogee Therapeutics, Inc.
47.21
+6.09%